Macias William L. — SEC Form 4 filings
SEC reporting owner CIK 1864280. 11 Form 4 filings on record with FilingPulse; latest filed 2025-02-21.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-01-19 to 2025-02-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 21 legs across 10 filings — 31,222 shares, $898,150 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 2.
- Largest priced transaction: sale of 6,136 shares @ $28.80 ($176,717) in Immunovant, Inc., filed 2024-04-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Immunovant, Inc. (IMVT) | Chief Medical Officer | 11 | — | 21 legs · 31,222 sh · $898,150 | 2 |
Form 4 filings — Macias William L.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-02-21 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 2,055 @ $20.86 | EDGAR |
| 2025-01-17 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 1,883 @ $23.81 · Sale (S): 94 @ $24.19 · Sale (S): 387 @ $23.81 · Sale (S): 19 @ $24.19 | EDGAR |
| 2024-11-22 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 3,353 @ $25.45 | EDGAR |
| 2024-10-18 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 2,627 @ $28.79 · Sale (S): 561 @ $28.79 | EDGAR |
| 2024-08-23 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 2,907 @ $31.84 · Sale (S): 120 @ $32.32 | EDGAR |
| 2024-07-19 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 2,362 @ $29.64 · Sale (S): 147 @ $30.55 · Sale (S): 504 @ $29.64 · Sale (S): 31 @ $30.55 | EDGAR |
| 2024-05-24 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 3,247 @ $29.65 | EDGAR |
| 2024-04-19 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 6,136 @ $28.80 · Sale (S): 1,796 @ $29.94 · Sale (S): 269 @ $28.80 · Sale (S): 79 @ $29.94 | EDGAR |
| 2024-04-04 | 4 | Immunovant, Inc. (IMVT) | Grant/award (A): 54,978 @ $0 · Grant/award (A): 68,723 (derivative) @ $0 | EDGAR |
| 2024-02-23 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 2,221 @ $36.15 | EDGAR |
| 2024-01-19 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 424 @ $41.03 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1864280 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →